BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8325952)

  • 1. Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion.
    Andersen PH; Lund S; Vestergaard H; Junker S; Kahn BB; Pedersen O
    J Clin Endocrinol Metab; 1993 Jul; 77(1):27-32. PubMed ID: 8325952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
    Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
    Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: a longitudinal study.
    Vestergaard H; Weinreb JE; Rosen AS; Bjørbaek C; Hansen L; Pedersen O; Kahn BB
    J Clin Endocrinol Metab; 1995 Jan; 80(1):270-5. PubMed ID: 7829624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM.
    Dela F; Ploug T; Handberg A; Petersen LN; Larsen JJ; Mikines KJ; Galbo H
    Diabetes; 1994 Jul; 43(7):862-5. PubMed ID: 8013748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased insulin-stimulated glucose uptake in athletes: the importance of GLUT4 mRNA, GLUT4 protein and fibre type composition of skeletal muscle.
    Andersen PH; Lund S; Schmitz O; Junker S; Kahn BB; Pedersen O
    Acta Physiol Scand; 1993 Dec; 149(4):393-404. PubMed ID: 8128887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM.
    Pedersen O; Bak JF; Andersen PH; Lund S; Moller DE; Flier JS; Kahn BB
    Diabetes; 1990 Jul; 39(7):865-70. PubMed ID: 2354749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity.
    Kahn BB; Pedersen O
    Endocrinology; 1993 Jan; 132(1):13-22. PubMed ID: 8419118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.
    Zierath JR; He L; Gumà A; Odegoard Wahlström E; Klip A; Wallberg-Henriksson H
    Diabetologia; 1996 Oct; 39(10):1180-9. PubMed ID: 8897005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors.
    Kahn BB; Rosen AS; Bak JF; Andersen PH; Damsbo P; Lund S; Pedersen O
    J Clin Endocrinol Metab; 1992 May; 74(5):1101-9. PubMed ID: 1569156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone.
    Haber RS; Weinstein SP
    Diabetes; 1992 Jun; 41(6):728-35. PubMed ID: 1587399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats.
    Torrance CJ; Devente JE; Jones JP; Dohm GL
    Endocrinology; 1997 Mar; 138(3):1204-14. PubMed ID: 9048628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.
    Friedman JE; Dohm GL; Leggett-Frazier N; Elton CW; Tapscott EB; Pories WP; Caro JF
    J Clin Invest; 1992 Feb; 89(2):701-5. PubMed ID: 1737857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle.
    Vettor R; Fabris R; Serra R; Lombardi AM; Tonello C; Granzotto M; Marzolo MO; Carruba MO; Ricquier D; Federspil G; Nisoli E
    Int J Obes Relat Metab Disord; 2002 Jun; 26(6):838-47. PubMed ID: 12037655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients.
    Yki-Järvinen H; Vuorinen-Markkola H; Koranyi L; Bourey R; Tordjman K; Mueckler M; Permutt AM; Koivisto VA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):795-9. PubMed ID: 1517369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral glucose uptake and skeletal muscle GLUT4 content in man: effect of insulin and free fatty acids.
    Handberg A; Vaag A; Beck-Nielsen H; Vinten J
    Diabet Med; 1992; 9(7):605-10. PubMed ID: 1511565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of alcohol extract of Cornus officinalis Sieb. et Zucc on GLUT4 expression in skeletal muscle in type 2 (non-insulin-dependent) diabetic mellitus rats].
    Qian DS; Zhu YF; Zhu Q
    Zhongguo Zhong Yao Za Zhi; 2001 Dec; 26(12):859-62. PubMed ID: 12776340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intensive insulin therapy on the insulin-regulatable glucose transporter (GLUT4) expression in skeletal muscle in type 1 diabetes.
    Andersen PH; Vestergaard H; Lund S; Vedel P; Junker S; Kahn BB; Pedersen O
    Diabet Med; 1993 Oct; 10(8):699-706. PubMed ID: 7505214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man.
    Koranyi LI; Bourey RE; Vuorinen-Markkola H; Koivisto VA; Mueckler M; Permutt MA; Yki-Järvinen H
    Diabetologia; 1991 Oct; 34(10):763-5. PubMed ID: 1959709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression.
    Brichard SM; Assimacopoulos-Jeannet F; Jeanrenaud B
    Endocrinology; 1992 Jul; 131(1):311-7. PubMed ID: 1612011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.